How should tetracaine (Tetricane) 0.5% ophthalmic eye drops be administered, including dosing, contraindications, and adverse effects?

Tetracaine 0.5% Ophthalmic Eye Drops: Administration Guide

Tetracaine 0.5% ophthalmic solution should be administered as 1-2 drops instilled directly into the eye(s), with dosing frequency and total number of applications determined by the specific procedure being performed. 1

Dosing by Clinical Indication

For Brief Diagnostic Procedures (Tonometry, Brief Examinations)

• Instill 1-2 drops immediately prior to the procedure 1
• Single application provides adequate anesthesia for short-duration evaluations
• Onset of action occurs within 4-6 minutes with peak effect at approximately 5 minutes 2

For Minor Surgical Procedures (Foreign Body Removal, Suture Removal)

• Administer 1-2 drops every 5-10 minutes for 1-3 total instillations 1
• This provides approximately 30 minutes of corneal anesthesia 3
• Multiple doses extend duration of maximal anesthetic effect to approximately 15-16 minutes 3

For Prolonged Procedures (Cataract Extraction)

• Instill 1-2 drops every 5-10 minutes for 3-5 total doses 1
• Provides extended anesthesia for longer surgical interventions
• Research demonstrates adequate pain control for phacoemulsification procedures 4, 5

Critical Contraindications and Warnings

Absolute Contraindications for Home Use

Tetracaine should NEVER be dispensed for routine home use or chronic administration due to risk of corneal epithelial toxicity, delayed healing, and potential for abuse. The FDA labeling explicitly states "FOR CLINIC USE ONLY" and "SINGLE USE ONLY" 1.

Limited Exception for Simple Corneal Abrasions

Recent consensus guidelines 6 suggest that for simple corneal abrasions only, it may be safe to provide tetracaine for home use under strict conditions:

• Maximum 24-hour supply only (1.5-2 mL total)
• Use every 30 minutes as needed
• All remaining medication must be discarded after 24 hours
• Only for simple corneal abrasions (no infection, no contact lens wear, no penetrating injury)

This represents a significant departure from traditional teaching and should only be implemented following the full diagnostic protocol outlined in the consensus guidelines 6.

Key Adverse Effects and Safety Concerns

Corneal Toxicity

• Repeated or prolonged use causes corneal epithelial damage
• Traditional teaching has prohibited home dispensing for this reason
• Recent studies 7, 8 suggest 24-hour use for simple corneal abrasions may be safe, though confidence intervals remain wide

Common Side Effects

• Transient stinging upon instillation
• Temporary loss of corneal protective reflexes
• Subjective numbness extending to maxillary teeth (reported in 80% with higher concentrations) 2

Infection Control Considerations

The conjunctivitis guideline 9 emphasizes proper tonometer disinfection when using anesthetic drops for tonometry:

• Use 1:10 dilute bleach (sodium hypochlorite) for tonometer disinfection
• 70% isopropyl alcohol is no longer recommended
• Single-use disposable tonometer tips eliminate sterilization concerns

Clinical Pitfalls to Avoid

1. Do not confuse simple with complicated corneal abrasions: Only simple abrasions (no infection, foreign body removed, no contact lens involvement) qualify for potential home use under new guidelines 6

2. Do not provide unlimited supply: Maximum 1.5-2 mL (24-hour supply) if dispensing for home use 6

3. Do not use for viral or bacterial conjunctivitis: The guideline 9 explicitly warns against indiscriminate use of topical agents for conjunctivitis, which is often self-limited

4. Do not assume all topical anesthetics are equivalent: Tetracaine is more potent than lidocaine, with faster onset (4 minutes vs 6 minutes) and longer duration 2

Product Specifications

• Supplied as: 0.5% solution in 15 mL plastic bottles with controlled drop tip 1
• Storage: Single-use designation per FDA labeling 1
• Concentration: 0.5% is standard for ophthalmic use; higher concentrations (1-2%) provide longer duration but are typically reserved for nasal/ENT applications 2